Early access
Sign in
Not yet taking people in GermanyPhase 1

Tests PRO-203 in healthy volunteers and people with systemic sclerosis

Tests the drug PRO-203 in healthy adults and adults with systemic sclerosis.

Key facts

Who runs it
Prolium Bioscience Inc.
Where
Duesseldorf, Frankfurt Am Main, Jena, Luebeck, and Munich, GermanySee the 5 sites
Trial code
Registry title
A Study of PRO-203 in Healthy Volunteers and Participants with Systemic Sclerosis
Status
Not yet recruiting
Phase
Phase 1
People taking part
9 people, planned
Started
3 Aug 2026
Expected to end
23 Apr 2027
Type of study
Interventional
Record updated
30 September 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults aged 18 to 64 with systemic sclerosis. Healthy volunteers are also part of the study.

Age
18 to 64 years
Sex
All sexes can join.

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 64 years old?

Where in Germany

  • Universitaetsklinikum Duesseldorf AöRDuesseldorf, GermanyNot yet recruiting
  • Fraunhofer Institute For Translational Medicine And Pharmacology ITMPFrankfurt Am Main, GermanyNot yet recruiting
  • Universitaetsklinikum Jena KöRJena, GermanyNot yet recruiting
  • Universitaetsklinikum Schleswig-Holstein AöRLuebeck, GermanyNot yet recruiting
  • LMU Klinikum Muenchen AöRMunich, GermanyNot yet recruiting

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).
Plain-language title
Tests PRO-203 in healthy volunteers and people with systemic sclerosisGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 9 November 2026.
Fit questions
Built from 2026-526659-70-00, who can take part
Record updated
30 September 2026